Search Within

Vincent Miller

  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (6)
Groups
  1. Advanced Practice Providers (13)
  2. Department of Medicine (13)
  3. Solid Tumor Oncology Division (13)
  4. Thoracic Oncology (13)
  5. Nursing (11)
  6. Survivorship Research (10)

More Groups

People
  1. Mark Kris (13)
  2. Christopher Azzoli (10)
  3. Lee Krug (10)
  4. Megan Dunne (10)
  5. Leslie Tyson (8)
  6. Naiyer Rizvi (7)

More People

Years
  1. 2019 (1)
  2. 2011 (1)
  3. 2008 (1)
  4. 2007 (5)
  5. 2006 (1)
  6. 2005 (1)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Cancer (2)
  3. Clinical Cancer Research (2)
  4. Journal of Thoracic Oncology (2)
  5. Molecular Cancer Therapeutics (2)
  6. Cold Spring Harbor Molecular Case Studies (1)
Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Clinical Oncology (4)
  3. Elsevier Inc. (2)
  4. Wiley Blackwell (2)
  5. Cold Spring Harbor Laboratory Press (1)

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Exceptional responders with invasive mucinous adenocarcinomas: A phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers
    Journal Article

    Drilon, A.; Schoenfeld, A. J.; Arbour, K. C.; Litvak, A.; Ni, A.; Montecalvo, J.; Yu, H. A.; Panora, E.; Ahn, L.; Kennedy, M.; more...
    Cold Spring Harbor Molecular Case Studies (2019)

    Fulltext@MSK | Save
  • Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: Safety and efficacy in a phase 1 trial
    Journal Article

    Azzoli, C. G.; Patel, J. D.; Krug, L. M.; Miller, V.; James, L.; Kris, M. G.; Ginsberg, M.; Subzwari, S.; Tyson, L.; Dunne, M.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Activity of XL647 in clinically selected NSCLC patients (pts) enriched for the presence of EGFR mutations: Results from Phase 2
    Meeting Abstract

    Rizvi, N. A.; Kris, M. G.; Miller, V. A.; Krug, L. M.; Bekele, S.; Dowlati, A.; Rowland, K. M.; Salgia, R.; Aggarwal, N.; Gadgeel, S. M.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase I study of the antifolate pralatrexate given with vitamin B(12) and folic acid supplementation in patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Azzoli, C. G.; Krug, L.; Miller, V.; Bekele, S.; Tyson, L.; Dunne, M.; Huntington, M.; Saunders, M.; Kris, M. G.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A phase II study of XL647 in patients with non-small cell lung cancer (NSCLC) enriched for presence of EGFR mutations
    Meeting Abstract

    Rizvi, N.; Kris, M.; Miller, V.; Krug, L.; Bekele, S.; Dowlati, A.; Rowland, K.; Tonda, M.; Mitchell, B.; Ruckdeschels, J.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • Phase I study of the anitfolate pralatrexate given with vitamin B12 and folic acid supplementation in patients with advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    James, L. P.; Azzoli, C. G.; Krug, L. M.; Miller, V.; Tripathi, P.; Subzwari, S.; Tyson, L. B.; Dunne, M.; Huntington, M. F.; Saunders, M. E.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • A phase II tolerability study of cisplatin plus docetaxel as adjuvant chemotherapy for resected non-small cell lung cancer
    Journal Article

    Azzoli, C. G.; Krug, L. M.; Miller, V. A.; Rizvi, N. A.; Kris, M. G.; Dunne, M.; Farmer, A.; Pizzo, B.; Tyson, L.; Seeger, T.; more...
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors
    Journal Article

    Azzoli, C. G.; Krug, L. M.; Gomez, J.; Miller, V. A.; Kris, M. G.; Ginsberg, M. S.; Henry, R.; Jones, J.; Tyson, L.; Dunne, M.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • A Phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer
    Journal Article

    Milton, D. T.; Azzoli, C. G.; Heelan, R. T.; Venkatraman, E.; Gomez, J. E.; Kris, M. G.; Krug, L. M.; Pao, W.; Rizvi, N. A.; Dunne, M.; more...
    Cancer (2006)

    Fulltext@MSK | Save
  • Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: A phase II clinical trial
    Journal Article

    Krug, L. M.; Crapanzano, J. P.; Azzoli, C. G.; Miller, V. A.; Rizvi, N.; Gomez, J.; Kris, M. G.; Pizzo, B.; Tyson, L.; Dunne, M.; more...
    Cancer (2005)

    Fulltext@MSK | Save